Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GOGL
5076
DELISTED
Golden Ocean Group
GOGL
| $186K | ﹤0.01% |
+24,692
| New | +$206K |
|
5077
LifeMD
LFMD
$156M
| $186K | ﹤0.01% |
42,756
-34,131
| -44% | -$75.8K |
|
5078
Ispire Technology
ISPR
$84.4M
| $185K | ﹤0.01% |
+20,335
| New | +$165K |
|
5079
CALL
Abeona Therapeutics
ABEO
$344M
| $185K | ﹤0.01% |
+46,000
| New | +$161K |
|
5080
Flux Power
FLUX
$14.1M
| $185K | ﹤0.01% |
42,886
-49,530
| -54% | -$192K |
|
|
WMC
5081
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $185K | ﹤0.01% |
20,822
-5,464
| -21% | -$47.5K |
|
5082
Lands' End
LE
$374M
| $185K | ﹤0.01% |
23,786
+10,542
| +80% | +$85.1K |
|
5083
Kearny Financial
KRNY
$639M
| $184K | ﹤0.01% |
+26,127
| New | +$194K |
|
5084
Theravance Biopharma
TBPH
$884M
| $184K | ﹤0.01% |
17,769
-121,937
| -87% | -$1.35M |
|
5085
First Community Corp
FCCO
$313M
| $184K | ﹤0.01% |
10,586
-1,951
| -16% | -$35.8K |
|
5086
AstroNova
ALOT
$227M
| $184K | ﹤0.01% |
+12,660
| New | +$189K |
|
5087
Kartoon Studios
TOON
$40.3M
| $183K | ﹤0.01% |
96,017
-72,391
| -43% | -$192K |
|
5088
CALL
Itaú Unibanco
ITUB
$83.9B
| $183K | ﹤0.01% |
35,123
+4,532
| +15% | +$21.4K |
|
5089
Mayville Engineering Co
MEC
$527M
| $182K | ﹤0.01% |
14,632
-96,372
| -87% | -$1.22M |
|
|
CLYM
5090
Climb Bio
CLYM
$924M
| $182K | ﹤0.01% |
64,931
-2,690
| -4% | -$8.17K |
|
5091
Nuveen Quality Municipal Income Fund
NAD
$2.73B
| $182K | ﹤0.01% |
+16,111
| New | +$181K |
|
|
SHCR
5092
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $181K | ﹤0.01% |
103,537
-84,803
| -45% | -$133K |
|
|
FLNT
5093
Fluent
FLNT
$123M
| $180K | ﹤0.01% |
47,805
-10,552
| -18% | -$44.4K |
|
5094
Urban One Class D
UONEK
$20.9M
| $180K | ﹤0.01% |
+2,995
| New | +$170K |
|
|
PLM
5095
DELISTED
PolyMet Mining Corp.
PLM
| $180K | ﹤0.01% |
227,299
+162,284
| +250% | +$243K |
|
|
ADVM
5096
DELISTED
Adverum Biotechnologies
ADVM
| $179K | ﹤0.01% |
11,233
-10,866
| -49% | -$114K |
|
5097
Century Therapeutics
IPSC
$388M
| $177K | ﹤0.01% |
56,009
-19,545
| -26% | -$63K |
|
5098
Gran Tierra Energy
GTE
$357M
| $177K | ﹤0.01% |
36,037
-38,583
| -52% | -$255K |
|
5099
CALL
UiPath
PATH
$8.68B
| $176K | ﹤0.01% |
+10,600
| New | +$170K |
|
|
5100
PUT
UiPath
PATH
$8.68B
| $176K | ﹤0.01% |
+10,600
| New | +$170K |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.